About Human Papillomavirus (HPV) Vaccine Research
Human Papillomavirus (HPV) is a common sexually transmitted infection (STI) that can lead to various health problems, including certain types of cancers. HPV infections are highly prevalent, and they can affect both males and females. To combat the impact of HPV, research on developing vaccines is crucial. By studying HPV and developing effective vaccines, scientists aim to prevent HPV infections and reduce the risk of associated diseases, such as cervical, anal, and oropharyngeal cancers. HPV vaccines are designed to provide long-lasting protection against the most common types of HPV. This research plays a vital role in promoting public health, especially for young individuals who can benefit from early vaccination to protect themselves from HPV-related diseases in the future.
Why Participate
You can help advance medicine by joining a clinical trial at Velocity, and you may also:
- Learn about potential new medicines in development
- Get study-related medical exams at no cost
- Receive compensation for participating (available amounts may differ for each study)
After you submit your information, a Velocity enrollment specialist will contact you. Together, we’ll review studies that might be right for you and answer your questions.
Health insurance is NOT required to join. There is never an obligation to participate — we’re here to help you make the best decision.
For more information about currently enrolling research studies, complete the form on this page or select a location below to get in touch with a Velocity enrollment specialist.
